Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study

American Journal of Gastroenterology

Volumn 112, Issue 6, 2017, Pages 940-947

  Staley, Christopher ^a   Hamilton, Matthew J ^a   Vaughn, Byron P ^b   Graiziger, Carolyn T ^b   Newman, Krista M ^b   Kabage, Amanda J ^b   Sadowsky, Michael J ^a   Khoruts, Alexander ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIDAXOMICIN; METRONIDAZOLE; RIFAXIMIN; VANCOMYCIN; MICROCAPSULE; RNA 16S;

ADULT; ARTICLE; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; ENCAPSULATION; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; FEMALE; FREEZE DRYING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROBIAL COMMUNITY; MICROBIOME; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RECURRENT INFECTION; TEMPERATURE; AGED; ANIMAL; BACTEROIDETES; CHEMISTRY; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FIRMICUTES; ISOLATION AND PURIFICATION; MICROBIAL VIABILITY; MICROBIOLOGY; MICROCAPSULE; MIDDLE AGED; MOUSE; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; PROTEOBACTERIA; RECURRENT DISEASE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; BACTEROIDETES; CAPSULES; CLOSTRIDIUM DIFFICILE; COHORT STUDIES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECAL MICROBIOTA TRANSPLANTATION; FECES; FEMALE; FIRMICUTES; FREEZE DRYING; HUMANS; MALE; MICE; MICROBIAL VIABILITY; MIDDLE AGED; PROTEOBACTERIA; RECURRENCE; RNA, RIBOSOMAL, 16S;

EID: 85012894735     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2017.6     Document Type: Article

References (38)

1. Spellberg B, Guidos R, Gilbert D et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 155-64.
2. Fauci AS, Marston LD. The perpetual challenge of antimicrobial resistance. JAMA 2014; 311: 1853-4.
3. Pamer EG. Resurrecting the intestinal microbiota to combat antibioticresistant pathogens. Science 2016; 352: 535-8.
4. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2012; 9: 88-96.
5. Drekonja D, Reich J, Gezahegn S et al. Fecal microbiota transplantation for Clostridium diffi cile infection: a systematic review. Ann Intern Med 2015; 162: 630-8.
6. van Nood E, Vrieze A, Nieuwdorp M et al. Duodenal infusion of donor feces for recurrent Clostridium diffi cile. N Engl J Med 2013; 368: 407-15.
7. Hamilton MJ, Weingarden AR, Sadowsky MJ et al. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium diffi cile infection. Am J Gastroenterol 2012; 107: 761-7.
8. Khoruts A, Rank KM, Newman KM et al. Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium diffi cile infection. Clin Gastroenterol Hepatol 2016; 14: 1433-8.
9. Zipursky JS, Sidorsky TI, Freedman CA et al. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium diffi cile infection. Clin Infect Dis 2012; 55: 1652-8.
10. Youngster I, Russell GH, Pindar C et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium diffi cile infection. JAMA 2014; 312: 1772-8.
11. Sogin ML, Morrison HG, Huber JA et al. Microbial diversity in the deep sea and the underexplored "rare biosphere". Proc Natl Acad Sci USA 2006; 103: 12115-20.
12. Claesson MJ, Wang Q, O'Sullivan O et al. Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions. Nucleic Acids Res 2010; 38: e200.
13. Schloss PD, Westcott SL, Ryabin T et al. Introducing mothur: open-source, platform-independent, community-supported soft ware for describing and comparing microbial communities. Appl Environ Microbiol 2009; 75: 7537-41.
14. Staley C, Gould TJ, Wang P et al. Evaluation of water sampling methodologies for amplicon-based characterization of bacterial community structure. J Microbiol Methods 2015; 114: 43-50.
15. Aronesty E. Comparison of sequencing utility programs. Open Bioinforma J 2013; 7: 1-8.
16. Pruesse E, Quast C, Knittel K et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res 2007; 35: 7188-96.
17. Huse SM, Welch DM, Morrison HG et al. Ironing out the wrinkles in the rare biosphere through improved OTU clustering. Environ Microbiol 2010; 12: 1889-98.
18. Edgar RC, Haas BJ, Clemente JC et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 2011; 27: 2194-200.
19. Gihring TM, Green SJ, Schadt CW. Massively parallel rRNA gene sequencing exacerbates the potential for biased community diversity comparisons due to variable library sizes. Environ Microbiol 2012; 14: 285-90.
20. Cole JR, Wang Q, Cardenas E et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 2009; 37: D141-5.
21. Knights D, Kuczynski J, Charlson ES et al. Bayesian community-wide culture-independent microbial source tracking. Nat Methods 2011; 8: 761-3.
22. Excoffi er L, Smouse PE, Quattro JM. Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 1992; 131: 479-91.
23. Clarke KR. Non-parametric multivariate analyses of changes in community structure. Aust. J. Ecol. 1993; 18: 117-43.
24. Hubalek Z. Protectants used in the cryopreservation of microorganisms. Cryobiology 2003; 46: 205-29.
25. Weingarden A, Gonzalez A, Vazquez-Baeza Y et al. Dynamic changes in short-and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium diffi cile infection. Microbiome 2015; 3: 10.
26. Hamilton MJ, Weingarden AR, Unno T et al. High-throughput DNA sequence analysis reveals stable engraft ment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 2013; 4: 125-35.
27. Weingarden AR, Chen C, Bobr A et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium diffi cile infection. Am J Physiol Gastrointest Liver Physiol 2014; 306: G310-9.
28. Shankar V, Hamilton MJ, Khoruts A et al. Species and genus level resolution analysis of gut microbiota in Clostridium diffi cile patients following fecal microbiota transplantation. Microbiome 2014; 2: 13.
29. Shahinas D, Silverman M, Sittler T et al. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. MBio 2012; 3: e00338-12.
30. Seekatz AM, Aas J, Gessert CE et al. Recovery of the gut microbiome following fecal microbiota transplantation. MBio 2014; 5: e00893-14.
31. Surawicz CM, Brandt LJ, Binion DG et al. Guidelines for diagnosis, treatment, and prevention of Clostridium diffi cile infections. Am J Gastroenterol 2013; 108: 478-98; quiz 499.
32. Lee CH, Steiner T, Petrof EO et al. Frozen vs. fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium diffi cile infection: a randomized clinical trial. JAMA 2016; 315: 142-9.
33. Youngster I, Sauk J, Pindar C et al. Fecal microbiota transplant for relapsing Clostridium diffi cile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis 2014; 58: 1515-22.
34. Youngster I, Mahabamunuge J, Systrom HK et al. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium diffi cile infection. BMC Med 2016; 14: 134.
35. Hirsch BE, Saraiya N, Poeth K et al. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium diffi cile infection. BMC Infect Dis 2015; 15: 191.
36. Orenstein R, Dubberke E, Hardi R et al. Safety and durability of RBX2660 (microbiota suspension) for recurrent Clostridium diffi cile infection: results of the PUNCH CD study. Clin Infect Dis 2016; 62: 596-602.
37. Wadhwa A, Al Nahhas MF, Dierkhising RA et al. High risk of postinfectious irritable bowel syndrome in patients with Clostridium diffi cile infection. Aliment Pharmacol Ther 2016; 44: 576-82.
38. Shaughnessy MK, Bobr A, Kuskowski MA et al. Environmental contamination in households of patients with recurrent Clostridium diffi cile Infection. Appl Environ Microbiol 2016; 82: 2686-92.